Modulation of Binding at Opioid Receptors by Monoand Divalent Cations and by Cholinergic Compounds

References

• Pert C. B., Snyder S. H. Opiate receptor: demonstration in nervous tissue. Science (Washington D.C.) 1973; 179: 1011–1014
   PubMed Web of Science ®Google Scholar
• Simon E. J., Hiller J. M., Edelman I. Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 1973; 70: 1947–1949
   PubMed Web of Science ®Google Scholar
• Pert C. B., Snyder S. H. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 1974; 10: 868–879
   Web of Science ®Google Scholar
• Simon E. J., Hiller J. M., Groth J., Edelman I. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. J. Pharmacol. Exp. Ther. 1975; 192: 531–537
   PubMed Web of Science ®Google Scholar
• Kouakou Y., Zajac J. M., Moisand C., Meunier J. C. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Mol. Pharmacol. 1982; 21: 564–569
   Google Scholar
• Pfeiffer A., Herz A. Enhancement of δ- but not of μ-opiate agonist binding by calcium. Naunyn-Schmiedeberg's Arch. Pharmacol. 1982; 319: 147–153
   Google Scholar
• Pfeiffer A., Sadée W., Herz A. Differential regulation of the μ-, δ-, and α-opiate receptor subtypes by guanyl nucleotides and metal ions. J. Neurosci. 1982; 2: 912–917
   Google Scholar
• Chang K.-J., Blanchard S. G., Cuatrecasas P. Unmasking of magnesium-dependent high-affinity binding sites for [D-Ala2,D-Leu5]enkephalin after pretreatment of brain membranes with guanine nucleotides. Proc. Natl. Acad. Sci. USA 1983; 80: 940–944
   Google Scholar
• Zajac J.-M., Roques B. P. Differences in binding properties of μ and δ opioid receptor subtypes from rat brain: Kinetic analysis and effects of ions and nucleotides. J. Neurochem. 1985; 44: 1605–1614
   Google Scholar
• Puttfarcken P., Werling L. L., Brown S. R., Cote T. E., Cox B. M. Sodium regulation of agonist binding at opioid receptors. I. Effect of sodium replacement on binding at μ- and δ-type receptors in 7315C and NG 108–15 cells and cell membranes. Mol. Pharmacol. 1986; 30: 81–89
   Google Scholar
• Werling L. L., Brown S. R., Puttfarcken P., Cox B. M. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacment on opioid binding in guinea pig cortical membranes. Mol. Pharmacol. 1986; 30: 90–95
   Google Scholar
• Paterson S. J., Robson L. E., Kosterlitz H. W. Control by cations of opioid binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 1986; 83: 6216–6220
   Google Scholar
• Meunier J.-C., Kouakou Y., Puget C., Moisand C. Multiple opiate receptor binding sites in the central nervous system of the rabbit. Large predominance of a μ subtype in the cerebellum and characterization of the kappa subtype in the thalamus. Mol. Pharmacol. 1983; 24: 23–29
   PubMed Web of Science ®Google Scholar
• Kosterlitz H. W., Paterson S. J., Robson L. E., Traynor J. R. Effects of cations on binding,in membrane suspensions, of various opioids at μ-sites of rabbit cerebellum and α-sites of guinea-pig cerebellum. Brit. J. Pharmacol. 1987, in press
   Google Scholar
• Robson L. E., Foote R. W., Maurer R., Kosterlitz H. W. Opioid binding sites of the α-type in guinea-pig cerebellum. Neuroscience 1984; 12: 621–627
   PubMed Web of Science ®Google Scholar
• Kosterlitz H. W., Corbett A. D., Gillan M. G. C., McKnight A. T., Paterson S. J., Robson L. E. Recent developments in bioassay using selective ligands and selective in vitro preparations. Opioid Peptides: Molecular Pharmacology, Biosynthesis, and Analysis, R. S. Rapaka, R. L. Hawks. U.S. Government Printing Office, Washington, DC 1986; 223–236, NIDA Research Monograph 70
   Google Scholar
• Corbett A. D., Gillan M. G. C., Kosterlitz H. W., Paterson S. J. Binding and pharmacological profile of a highly selective ligand for the α-opioid receptor - U-69,593. Brit. J. Pharmacol. 1985; 86: 704P
   Google Scholar
• Corbett A. D., Kosterlitz H. W. Bremazocine is an agonist at α-opioid receptors and an antagonist at μ-opioid receptors in the guinea-pig myenteric plexus. Brit. J. Pharmacol. 1986; 89: 245–249
   Google Scholar
• McKnight A. T., Corbett A. D., Marcoli M., Kosterlitz H. W. The opioid receptors in the hamster vas deferens are of the δ-type. Neuropharmacology 1985; 24: 1011–1017
   Google Scholar